HER2 immunohistochemistry staining positivity is strongly predictive of tumor response to neoadjuvant chemotherapy in HER2 positive breast cancer.

By J. Zhao, U. Krishnamurti, Chao Zhang, J. Meisel, Zhimin Wei, Aili Suo, R. Aneja, Zaibo Li, Xiaoxian Li. 2020

Subfields: Cancer Research, Oncology, Pathology and Forensic Medicine